Hellström C

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

Havervall S, Jernbom Falk A, Klingström J, ..., Nilsson P, Thålin C

PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals

Healy K, Pin E, Chen P, ..., Aleman S, Sällberg Chen M

Med (N Y) - (-) - [2022-01-00; online 2022-01-00]

Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab Funder: VR Research Area: Vaccine Type: Journal article

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C

J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.

Rudberg AS, Havervall S, Månberg A, ..., Hober S, Thålin C

Nat Commun 11 (1) 5064 [2020-10-08; online 2020-10-08]

Category: Health Category: Serology Funder: H2020 Funder: KAW/SciLifeLab Funder: VR Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article